Besim Prnjavorac

Besim Prnjavorac

Auto-generated profile, based on publicly available information

Besim Prnjavorac

Department of Pathophysiology, School of Medicine, Sarajevo School of Science and Technology, Sarajevo, Bosnia and Herzegovina

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023
Verified
Journal Article
Open access
ARAida Ramic-Catak
Aida Ramic-Catak
SMSenka Mesihović-Dinarevic
Senka Mesihović-Dinarevic
BPBesim Prnjavorac
Besim Prnjavorac
CVD remains a leading cause of death in Europe and worldwide accounting for 3.9 million deaths each year in Europe alone. Even with well-known risk factors and the current standards of health care, improvement of health and quality of life of CVD patients are still remains one of the biggest public health challenges we must overcome. The aim of this narrative review is to provide a brief overview of the recent and relevant documents of good practice in prevention, diagnostic and therapeutic approaches of Cardiovascular diseases that should be consider as milestones for the health authorities in the Federation of BiH. Cardiovascular diseases stil represent a worldwide public health problem, with some new dimensions caused by challenges caused through pandemic of COVID-19. The wellknown cardiovascular risk factors require new and more efficient public health approaches to the prevention and control. Due to the recently developed cardiovascular guidelines that were made by the European Society of Cardiology and World Heart Federation, key priority for health authorities should be is to update the existing CVD guidelines in the Federation of BiH in accordance with the international good practice.

1 August 2021 in Acta Scientific Medical Sciences
Verified
Journal Article
Open access
Emina K. SherEmina K. Sher
Emina K. Sher
BPBesim Prnjavorac
Besim Prnjavorac
TBTamer Bego
Tamer Bego
NMNeven Meseldžić
Neven Meseldžić
SISelma Imamović
Selma Imamović
EBEdin Begic
Edin Begic

17 June 2026 in Medicinski Glasnik
Verified
Journal Article
Open access
PDF file
AMAida Mujaković
Aida Mujaković
MHMihana Hasak Hassan
Mihana Hasak Hassan
BPBesim Prnjavorac
Besim Prnjavorac
NMNejra Mlaco-Vrazalic
Nejra Mlaco-Vrazalic
AMAkif Mlačo
Akif Mlačo
Aim: To determine if heat-not-burn (HNB) tobacco products are a safe alternative to cigarette smoking by inducing decreased decline of cardiorespiratory function. Methods: A clinical observational, cross-sectional study was conducted in the period between February and June 2025. It analysed and identified the effects of HNB tobacco products on cardiorespiratory symptoms in 60 adults below 55 years of age with confirmed arterial hypertension, 30 in the HNB users group (≥6 months of HNB use and no history of conventional cigarette use (CCU)), and 30 in the non-HNB user group (no history of HNB or CCU). Results: The gender distribution among the groups was similar. HNB tobacco product users reported significantly more respiratory (daily and nighttime shortness of breath, coughing) and cardiologic symptoms (choking, shortness of breath during physical activity). The following parameters were significantly reduced in the HNB tobacco product users: forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), and forced expiratory flow at 75% (FEF75) (p = 0.01), SO₂ (p < 0.001), pO₂ (p = 0.001), HCO₃⁻ (p < 0.001), total cholesterol (p = 0.001), and basophils (p < 0.001), while the following parameters were significantly increased in the same group: right ventricular systolic pressure (RVSP) (p = 0.002), hsCRP (p < 0.001), monocytes (p < 0.001), eosinophils (p < 0.001), D-dimer (p < 0.001), and platelet count (p = 0.003). Conclusion: HNB tobacco product use in adults with arterial hypertension was associated with worse cardiorespiratory symptoms, impaired pulmonary function, signs of early right ventricular dysfunction, and systemic inflammation.


1 January 2025
Verified
Journal Article
Open access
AMAida Mujakovic
Aida Mujakovic
SSSaied Al Salloum
Saied Al Salloum
BPBesim Prnjavorac
Besim Prnjavorac
ECEmir Cokic
Emir Cokic
Introduction. The harmful effect of cigarette use has been proven through existing studies, but the recent advanced use of heat-not-burn-tobacco-products (HNB) and its effect remains under observation. Results. After six months, HNB users exhibited better-preserved FEV1 and peripheral oxygenation values. Conclusion. Patients using HNB tobacco products achieved better 6MWT and spirometry testing results and showed lower cholesterol and hs-CRP levels after six months of follow-up. Keywords: smoking, spirometry, heat-not-burn, lung function decline, respiratory health.

27 August 2022 in Medicinski Glasnik
Verified
Journal Article
Open access
AMAida Mujaković
Aida Mujaković
BPBelma Paralija
Belma Paralija
BPBesim Prnjavorac
Besim Prnjavorac
OLOrhan Lepara
Orhan Lepara
AFAlmir Fajkić
Almir Fajkić
MOMirad Odobašić
Mirad Odobašić
Aim To identify clinical and laboratory parameters on admission and/or during a hospital stay that would predict prolonged hospital stay in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).Methods A retrospective cross-sectional study was conducted at the Clinic for Pulmonary Diseases and Tuberculosis, Clinical Centre University of Sarajevo for the period 2019-2021 accounting patients admitted due to AECOPD. The need for hospitalization was evaluated according to the current GOLD criteria and certain clinical parameters. Spirometry testing and laboratory analysis were performed for all patients on the day of admission and on the 10th day of hospital stay. Linear regression was used to show the relationship between multiple independent predictor variablesand LOS.Results A total of 50 patients were evaluated during their hospital stay due to AECOPD. Median of LOS was 22.02±1.06, with 90%hospital survival rate. Due to AECOPD the median of LOS in the intensive care unit (ICU) was 4±0.68 days with pH<7.35 in 34% of hospitalized patients. According to spirometry classification on the day of admission, 56% of patients were assigned to group 3 and 16% to group 4 with significant improvement identified on spirometry findings on discharge. Platelets on the day of admission were the only statistically significant positive predictors of the length of hospital stay.Conclusion Identifying chronic obstructive pulmonary disease patients at risk of frequent exacerbations and appropriate diseasemanagement could reduce the disease burden.